17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The co‐regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Tumor suppressor genes (TSGs) and oncogenes (OG) are involved in carcinogenesis. MiRNAs also contribute to cellular pathways leading to cancer. We use data from 217 colorectal cancer (CRC) cases to evaluate differences in TSGs and OGs expression between paired CRC and normal mucosa and evaluate how TSGs and OGs are associated with miRNAs. Gene expression data from RNA‐Seq and miRNA expression data from Agilent Human miRNA Microarray V19.0 were used. We focus on genes most strongly associated with CRC (fold change (FC) of ≥1.5 or ≤0.67) that were statistically significant after adjustment for multiple comparisons. Of the 74 TSGs evaluated, 22 were associated with carcinoma/normal mucosa differential expression. Ten TSGs were up‐regulated ( FAM123B, RB1, TP53, RUNX1, MSH2, BRCA1, BRCA2, SOX9, NPM1, and RNF43); six TSGs were down‐regulated ( PAX5, IZKF1, GATA3, PRDM1, TET2, and CYLD); four were associated with MSI tumors ( MLH1, PTCH1, and CEBPA down‐regulated and MSH6 up‐regulated); and two were associated with MSS tumors ( PHF6 and ASXL1 up‐regulated). Thirteen of these TSGs were associated with 44 miRNAs. Twenty‐seven of the 59 OGs evaluated were dysregulated: 14 down‐regulated (KLF4, BCL2, SSETBP1, FGFR2, TSHR, MPL, KIT, PDGFRA, GNA11, GATA2, FGFR3, AR, CSF1R, and JAK3), seven up‐regulated (DNMT1, EZH2, PTPN11, SKP2, CCND1, MET, and MYC); three down‐regulated for MSI (FLT3, CARD11, and ALK); two up‐regulated for MSI (IDH2 and HRAS); and one up‐regulated with MSS tumors (CTNNB1). These findings suggest possible co‐regulatory function between TSGs, OGs, and miRNAs, involving both direct and indirect associations that operate through feedback and feedforward loops.

          Related collections

          Most cited references53

          • Record: found
          • Abstract: not found
          • Article: not found

          Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Structure and function of the feed-forward loop network motif.

            Engineered systems are often built of recurring circuit modules that carry out key functions. Transcription networks that regulate the responses of living cells were recently found to obey similar principles: they contain several biochemical wiring patterns, termed network motifs, which recur throughout the network. One of these motifs is the feed-forward loop (FFL). The FFL, a three-gene pattern, is composed of two input transcription factors, one of which regulates the other, both jointly regulating a target gene. The FFL has eight possible structural types, because each of the three interactions in the FFL can be activating or repressing. Here, we theoretically analyze the functions of these eight structural types. We find that four of the FFL types, termed incoherent FFLs, act as sign-sensitive accelerators: they speed up the response time of the target gene expression following stimulus steps in one direction (e.g., off to on) but not in the other direction (on to off). The other four types, coherent FFLs, act as sign-sensitive delays. We find that some FFL types appear in transcription network databases much more frequently than others. In some cases, the rare FFL types have reduced functionality (responding to only one of their two input stimuli), which may partially explain why they are selected against. Additional features, such as pulse generation and cooperativity, are discussed. This study defines the function of one of the most significant recurring circuit elements in transcription networks.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.

              MicroRNAs (miRNAs) are a class of naturally occurring small non-coding RNAs that target protein-coding mRNAs at the post-transcriptional level. Our previous studies suggest that mir-21 functions as an oncogene and has a role in tumorigenesis, in part through regulation of the tumor suppressor gene tropomyosin 1 (TPM1). Given that TPM1 has been implicated in cell migration, in this study we further investigated the role of mir-21 in cell invasion and tumor metastasis. We found that suppression of mir-21 in metastatic breast cancer MDA-MB-231 cells significantly reduced invasion and lung metastasis. Consistent with this, ectopic expression of TPM1 remarkably reduced cell invasion. Furthermore, we identified two additional direct mir-21 targets, programmed cell death 4 (PDCD4) and maspin, both of which have been implicated in invasion and metastasis. Like TPM1, PDCD4 and maspin also reduced invasiveness of MDA-MB-231 cells. Finally, the expression of PDCD4 and maspin inversely correlated with mir-21 expression in human breast tumor specimens, indicating the potential regulation of PDCD4 and maspin by mir-21 in these tumors. Taken together, the results suggest that, as an oncogenic miRNA, mir-21 has a role not only in tumor growth but also in invasion and tumor metastasis by targeting multiple tumor/metastasis suppressor genes. Therefore, suppression of mir-21 may provide a novel approach for the treatment of advanced cancers.
                Bookmark

                Author and article information

                Contributors
                marty.slattery@hsc.utah.edu
                Journal
                Genes Chromosomes Cancer
                Genes Chromosomes Cancer
                10.1002/(ISSN)1098-2264
                GCC
                Genes, Chromosomes & Cancer
                John Wiley and Sons Inc. (Hoboken )
                1045-2257
                1098-2264
                30 July 2017
                November 2017
                : 56
                : 11 ( doiID: 10.1002/gcc.v56.11 )
                : 769-787
                Affiliations
                [ 1 ] Department of Medicine University of Utah Salt Lake City Utah
                [ 2 ] Department of Pathology University of Utah Salt Lake City Utah
                [ 3 ] Department of Mathematics and Statistics Utah State University Logan Utah
                [ 4 ] Kaiser Permanente Medical Research Program Oakland California
                Author notes
                [*] [* ] Correspondence Martha L. Slattery, 383 Colorow, Salt Lake City, UT 84018. Email: marty.slattery@ 123456hsc.utah.edu
                Author information
                http://orcid.org/0000-0002-1655-6543
                http://orcid.org/0000-0003-0936-5957
                Article
                GCC22481
                10.1002/gcc.22481
                5597468
                28675510
                8f6683be-1cb5-41dc-9da5-082df9143046
                © 2017 Authors Genes, Chromosomes and Cancer Published by Wiley Periodicals, Inc.

                This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 06 June 2017
                : 30 June 2017
                : 01 July 2017
                Page count
                Figures: 0, Tables: 6, Pages: 19, Words: 9699
                Funding
                Funded by: National Cancer Institute
                Award ID: CA163683
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                gcc22481
                November 2017
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.2.1 mode:remove_FC converted:12.10.2017

                Oncology & Radiotherapy
                Oncology & Radiotherapy

                Comments

                Comment on this article